Author Archives: Karin Lillis

80% cut in antibiotics entering Thames is needed to avoid surge in superbugs

The amount of antibiotics entering the River Thames would need to be cut by as much as 80% to avoid the development and spread of antibiotic-resistant “superbugs,” a new study has shown. Scientists from the Centre for Ecology and Hydrology (CEH) modeled the effects of antibiotic prescriptions on the development of antibiotic-resistant bacteria in a river. It found that across ...

Read More »

New material could make it easier to remove colon polyps

More than 15 million colonoscopies are performed in the United States every year, and in at least 20 percent of those, gastroenterologists end up removing precancerous growths from the colon. Eliminating these early-stage lesions, known as polyps, is the best way to prevent colon cancer from developing. To reduce the risk of tearing the colon during this procedure, doctors often ...

Read More »

Scientists find urine test could offer a non-invasive approach for diagnosis of IBS

Scientists at McMaster University have identified new biomarkers for irritable bowel syndrome (IBS) in urine, which could lead to better treatments and reduce the need for costly and invasive colonoscopy procedures currently used for diagnosis. Little is known about the causes of IBS, a chronic and often debilitating gastrointestinal disorder which affects hundreds of thousands of Canadians in which diagnosis ...

Read More »

FDA halts fecal microbiota transplant after patient death

The U.S. Food and Drug Administration has issued a safety communication regarding the use of Fecal Microbiota for Transplantation (FMT) and the risk of serious or life-threatening infections due to transmission of multi-drug resistant organisms (MDROs), as well as protections FDA has determined are needed for patients receiving investigational FMT. Two immunocompromised adults who received investigational FMT developed invasive bacterial infections due ...

Read More »

Many patients with pancreatic cancer miss out on treatment that may extend survival

Despite potential for prolonging survival with treatment, one-third of patients with metastatic pancreatic cancer do not see a medical oncologist, and even more do not receive cancer-directed treatment, found new research published in CMAJ (Canadian Medical Association Journal). Pancreatic cancer has a high death rate and is often diagnosed in advanced stages. “The data suggest that there are many missed opportunities for important ...

Read More »